Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Sevelamer and Calcium Supplement

Research Papers that Mention the Interaction

Therapy with bisphosphonates, sevelamer and calcimimetics, as well as thyroidectomy for regulating mineral balance were anticipated to prevent calcium accumulation and inhibit VMSC apoptosis.
Expert review of cardiovascular therapy  •  2013  |  View Paper
Despite increased prevalence of DM in the sevelamer group (58%) as compared to the CBPB group (35%), CACS was significantly lower with sevelamer use (283 + or - 83 vs. 494 + or - 94, p = 0.02).
Clinical nephrology  •  2010  |  View Paper
Sevelamer treatment has reduced calcium concentration and increased PTH levels, resulting in the improvement of markers of bone turnover, increased bone formation and improved trabecular architecture, providing a slower progression of VC.
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia  •  2009  |  View Paper
RESULTS The switch from CaCO3 to se elamer si gnificantly decreased the serum levels of cal cium, r esulting in the elevation of iPTH levels from 31+/-18 pg/mL to 95+/-96 pg/mL by 48 weeks.
Internal medicine  •  2007  |  View Paper
We could decrease doses of calcium-based phosphate binders by using sevelamer hydrochloride , and that could lower the level of calcium and raise the level of intact PTH.
Clinical calcium  •  2005  |  View Paper
CONCLUSIONS In chronic HD patients, se elamer de creased serum total- and LDL-cholesterol as well as cal cium.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  •  2005  |  View Paper
In conclusion, the concomitant use of sevelamer as a phosphate binder and the dialysate of calcium concentration of 2.5 mEq/L have possibilities for worsening secondary hyperparathyroidism in patients receiving intravenous vitamin D.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy  •  2005  |  View Paper